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Abstract
The C/EBP Homologous Protein (CHOP) is a nuclear protein that is integral to the unfolded protein response culminating
from endoplasmic reticulum stress. Previously, CHOP was shown to comprise extensive disordered regions and to self-
associate in solution. In the current study, the intrinsically disordered nature of this protein was characterized further by
comprehensive in silico analyses. Using circular dichroism, differential scanning calorimetry and nuclear magnetic
resonance, we investigated the global conformation and secondary structure of CHOP and demonstrated, for the first time,
that conformational changes in this protein can be induced by the free amino acid L-cysteine. Addition of L-cysteine caused
a significant dose-dependent decrease in the protein helicity – dropping from 69.1% to 23.8% in the presence of 1 mM of L-
cysteine – and a sequential transition to a more disordered state, unlike that caused by thermal denaturation. Furthermore,
the presence of small amounts of free amino acid (80 mM, an 8:1 cysteine:CHOP ratio) during CHOP thermal denaturation
altered the molecular mechanism of its melting process, leading to a complex, multi-step transition. On the other hand, high
levels (4 mM) of free L-cysteine seemed to cause a complete loss of rigid cooperatively melting structure. These results
suggested a potential regulatory function of L-cysteine which may lead to changes in global conformation of CHOP in
response to the cellular redox state and/or endoplasmic reticulum stress.
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Introduction
C/EBP Homologous Protein (CHOP) is a nuclear protein that
acts as both a dominant-negative inhibitor of CCATT/enhancer
binding proteins (C/EBPs) and a transcriptional activator of
Activating Protein–1 (AP-1) [1]. This 29 kDa protein contains two
functional domains, an N-terminal transcriptional activation
domain and a C-terminal basic-leucine zipper (bZIP) domain
[1–3]. Two adjacent serine residues (Ser79 and Ser82) can be
phosphorylated by the p38 MAP kinase family [4]. CHOP plays
an integral role in one of the branches of the unfolded protein
response (UPR) which is initiated in response to endoplasmic
reticulum (ER) stress [5–8], and also occurs in response to factors
such as nutrient starvation, calcium depletion, inflammation,
glucose deprivation, and viral infection [5,9–11]. This response
promotes cellular recovery, and leads to apoptosis if recovery is not
possible. While the exact signaling mechanism underlying ER
stress-induced apoptosis is poorly understood, CHOP has been
implicated in two potential mechanisms. As a transcriptional
regulator, CHOP plays a role in linking ER stress to alterations in
gene expression, and it is a major pro-apoptotic component of the
UPR [1,12,13]; it represses Bcl2 and induces apoptotic proteins
such as Gadd34, Dr5, Bim and Trb3 [3,14–17]. CHOP has also
been shown to induce ER oxidase 1a (ERO1a) which, in turn,
activates IP3R1, the ER calcium-release channel found to be
crucial for mediating events triggered by cytoplasmic calcium. The
CHOP-ERO1a pathway directly promotes hyperoxidizing condi-
tions in the ER lumen and results in cytoplasmic oxidative stress by
inducing NADPH oxidase subunit Nox2 as well as by generation
of reactive oxygen species (reviewed in [8]). Deletion mutant
analysis of CHOP revealed that bZIP domain is important for
CHOP-induced apoptosis [18,19].
Despite its involvement in the UPR, to depict CHOP as purely
a pro-apoptotic transcription factor is an oversimplification.
Rather, CHOP has been suggested to mediate cell- and context-
specific responses to stress that are either adaptive or maladaptive
[20]. CHOP expression is induced in myoblasts to prevent
premature differentiation by binding to the upstream regulatory
region of the myod gene and repressing its transcription. Its activity
reduces histone acetylation at the MyoD enhancer region through
an interaction with histone deacetylase I (HDAC) [21]. In
oligodendrocytes, CHOP appears to protect against death while,
in contrast, CHOP promotes demyelination in Schwann cells
without cell death [20].
CHOP induction has been implicated in diseases such as homo-
cysteinemia, brain ischemia, human sarcomas, and neurodegen-
erative disorders [3,22–25]. It may contribute to heart attacks by
promoting apoptosis of the macrophages in atherosclerotic
plaques, which leads to plaque rupture [26], and CHOP-mediated
apoptosis subsequently contributes to reperfusion injury [27].
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triggered by misfolded (pro)insulin, present due to either over-
synthesis or mutations that inhibit processing, leading to CHOP-
mediated apoptosis [11,28]. Pathological effects might also be
caused by CHOP’s association with the immune response, through
its activation of the pro-inflammatory transcription factor NF-kB
[29]. Since CHOP itself is also triggered by inflammatory
cytokines [30], this represents a possibly dangerous positive
feedback loop when activated.
It is generally accepted that the biological function of a protein
is intimately related to its three-dimensional structure. Indeed, a
common approach to discerning the potential function of an
unannotated protein is by comparison with the unique structural
folds of known proteins. However, within the last decade, it has
become increasingly clear that a significant fraction of the
universal proteome consists of intrinsically disordered proteins
(IDPs) or proteins with intrinsically disordered regions (IDRs) [31–
35]. IDPs exist as dynamic ensembles in which the atom positions
and backbone Ramachandran angles vary significantly over time
with no specific equilibrium values, and typically undergo non-
cooperative conformational changes [31,35–46]. Numerous stud-
ies have demonstrated that many proteins and regions thereof
function in this intrinsically disordered (ID) state [35–37,47–50],
challenging the classical notion that the function of a protein is
predefined by its three-dimensional structure. Proteins with
ordered structures have mainly evolved for efficient catalysis
[51], whereas IDPs are typically involved in regulation, signaling
and control pathways [52–54] as the flexibility of disordered
regions allow interactions with several partners, promoting more
efficient use of the same protein in multiple pathways [55]. It is,
thus, not surprising that IDPs have been implicated in various
diseases such as cancer, cardiovascular disease, amyloidosis, and
neurodegenerative diseases [47,56].
Previously, we reported that CHOP is an IDP and that its
disordered N-terminal domain mediates oligomerization, which
plays a key role in its function in both inhibition of Wnt/Tcf
signaling as well as stimulation of c-Jun and sucrase-isomaltase
reporter activity in intestinal colon cancer cells [57]. IDPs such as
CHOP can bind partners with both high specificity and low
affinity [58], thus fulfilling the two fundamental requirements of
signaling interactions – specificity and reversibility [59]. Further-
more, IDRs possess tremendous binding diversity, able to interact
specifically with numerous partners, including proteins, nucleic
acids, polysaccharides and small molecules [35–37,40,41]. This
makes them ideal for playing important roles in the exquisitely
complex network of protein-protein interactions, as they can
achieve very high connectivity levels. As such, proteins such as
CHOP are known as ‘‘hub’’ proteins and it is precisely this
intrinsic disorder which is suggested to play a crucial role in hub
protein functions [53,54].
The binding promiscuity of IDPs, which gives them their
important role in signaling and regulatory functions, also demands
that they be under strict regulation and carefully monitored
[55,56,60]. Moreover, understanding this regulation is important
as irregular expression of IDPs is associated with several disease
states [47,55,60]. As such, the availability of IDPs is strictly
regulated at various levels from transcript synthesis to protein
degradation. Multiple mechanisms control availability at the level
of transcription and translation, including higher miRNA target
sites and higher mRNA decay rates, greater ubiquitination sites,
and increased susceptibility for degradation, all of which result in
many IDPs being present at relatively low levels and for shorter
periods of time than their structured counterparts. While this may
be the case for the majority of IDPs, some may be required at high
levels or for prolonged periods of time in response to certain
conditions or at certain phases of the cell cycle, or even required at
high levels during the entire cell’s lifetime. Some IDPs can be
stabilized by association with ‘‘nanny proteins’’ which bind to
IDRs and facilitate degradation, while others are stabilized by
becoming part of stable complexes or by interaction with other
partners. Post-translational modifications, such as phosphoryla-
tion, can influence the balance between the bound and unbound
states of these proteins (reviewed in [55]). On the other hand,
another concern originates from the flexibility and promiscuity of
IDPs, which leads to the question of what mechanisms are in place
to avoid unwanted interactions. One model set forth is the
functional misfolding of ‘‘sticky’’ preformed secondary structure
elements such that they are sequestered and excluded from the
environment as a means of ‘‘hiding’’ them from unwanted binding
interactions (reviewed in [56]).
In this study, we continue our structural characterization of
CHOP by investigating the regulation of this protein via analysis
of the effects of various thiols on its conformation. Levels of CHOP
have been shown to increase with those of homocysteine and
cysteine, conditions indicative of homocysteine stress [61].
Furthermore, CHOP translocation occurs under redox stress
[62]. Translocation through membranes is thought to be optimal
when a protein is in a ‘‘molten globule’’ state, i.e. a state
combining structural features of ordered and disordered confor-
mations [63]. Since CHOP is a prominent resident of the ER and
an aberrant-ER marker, and since intracellular thiols such as
cysteine, homocysteine, and glutathione play critical roles in the
regulation of ER protein synthesis and folding [64], in this study
we examined whether thiols could affect CHOP structure and
potentially play a regulatory role. We demonstrate that L-cysteine,
but not homocysteine or glutathione, affects the global conforma-
tion of CHOP in a concentration-dependent manner. Circular
dichroism (CD), differential scanning calorimetry (DSC), and
nuclear magnetic resonance (NMR) studies were employed to
show that conformational changes in CHOP can be induced by
the free amino acid L-cysteine (but not D-cysteine). This finding is
discussed as a plausible signal transduction mechanism during ER
stress-mediated apoptosis.
Results
Disorder analysis of CHOP
Previously, we reported that CHOP is an IDP based on in silico
amino acid sequence analyses, NMR and CD spectroscopy [57].
For the present study, a more comprehensive analysis was
performed to characterize the ‘‘disorderedness’’ of the protein.
There is vast structural variability of IDPs, ranging from being
completely unstructured, to containing some elements of second-
ary and/or tertiary structure, to molten globular proteins with
well-developed secondary structure and high compactness degree,
to domains (both ordered and disordered) containing highly
flexible linkers [45,65–67]. The various computational tools
available tend to use different criteria, attributes, algorithms and
databases to predict disorder and, up to now, there is no single
program which is accurate enough to be completely trusted for
reliability [68–71]. Consequently, we employed several different
programs (i.e., PONDR VLXT [72,73], PONDR VSL2 [74],
PONDR VL3 [75], IUPred [76], TopIDP [77], Foldindex [78]
and a meta predictor PONDR-FIT [79]) for the in silico analysis of
the amino acid sequence (Figure 1A), which consistently predicted
that CHOP is expected to be highly disordered over most of its
length when looking at the disorder predicted on a per-residue
basis. The C-terminus of CHOP is identified as a helical molecular
Cysteine Modulates CHOP Conformation
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has the tendency to adopt an a-helical conformation on binding of
a target protein [80].
Given the extreme conformational variability of IDPs, ranging
from collapsed molten globule-like disorder to extended coil-like
disorder, and given the coexistence of ordered and disordered
proteins, a binary classification can be performed to categorize the
protein as entirely disordered or ordered. One methodology
commonly used is a cumulative distribution function (CDF)
analysis, which improves the accuracy of disorder prediction on
the level of the whole protein [65]. In CDF analysis, a protein is
predicted to be mostly disordered if the majority of the resultant
curve is located below the boundary between ordered and
disordered proteins. With all of the algorithms utilized for this
analysis, the majority of the respective CDF curves for CHOP
resided below the boundary (Figure 1B), thus implying that CHOP
is expected to be disordered as a whole. Finally, an additional
binary classification was performed using a charge-hydropathy
plot to determine the linear boundary which separates compact
and extended proteins (Figure 1C) [81]. In the charge-hydropathy
plot, CHOP clearly falls in the region corresponding to the
natively unfolded proteins (i.e. IDPs with extended disorder), thus
further supporting its definition as a disordered protein.
CD analysis of CHOP secondary structure
Since CHOP is considered to serve as a potential ‘‘hub’’
protein, we attempted to investigate means by which it may be
regulated. We had already established that the disordered N-
terminal domain of CHOP mediates its oligomerization, its
putative native state, which plays a key functional role in
inhibition of Wnt/Tcf signaling as well as stimulation of c-Jun
and sucrase-isomaltase reporter activity in intestinal colon cancer
cells [57]. Given that (1) increases in levels of both homocysteine
and cysteine have been associated with increases in CHOP levels
[61], (2) that its translocation occurs under redox stress [62] and
that, generally, translocation through membranes is presumably
optimal when a protein is in a ‘‘molten globule’’ state (i.e. a state
characterized by a combination of features typical for ordered and
unfolded proteins) [63], (3) that CHOP is a prominent resident of
the ER and an aberrant-ER marker, and (4) that intracellular
thiols such as cysteine, homocysteine and glutathione play critical
roles in the regulation of ER protein synthesis and folding [64], we
investigated the effect of various thiols on CHOP structure.
Initially, circular dichroism (CD) was used to investigate changes
in secondary structure. Titration of CHOP with homocysteine,
glutathione and D-cysteine showed no change in conformation as
measured by CD (data not shown). However, L-cysteine affected
conformation.
Far-UV analysis on native CHOP revealed an intriguingly high
percentage of a-helical content for an apparently disordered
protein (Table 1). Our previous studies strongly predicted that that
C-terminal domain of CHOP contains a long coiled-coil region
[57]. Furthermore, it has been determined that the native protein
exists in an oligomeric state, formation of which is mediated by its
N-terminal disordered region, suggesting that CHOP oligomeri-
zation may involve the formation of an a-helical coiled-coil.
Titration of the native protein with L-cysteine resulted in changes
of the shape and intensity of the CHOP far-UV CD spectrum
(Figure 2). Notably, increasing amounts of L-cysteine resulted in
changes in the characteristic bands at 222, 208 and 190 nm, with
the appearance of a new band at 200 nm, implying a decrease in
ordered secondary structure content. More specifically, changes at
222 and 190 nm were attributed to a decrease in a-helical content
(Figure 2, inset). This hypothesis was supported by the deconvolu-
tion of the CD spectra [82], which revealed a concomitant
decrease in a-helical content with increasing concentrations of L-
cysteine, dropping from 69.1% to 23.8% in the presence of 1 mM
Figure 1. In silico disorder analysis of CHOP using various
prediction programs (IVLXT, VSL2, VL3, IUPred, TopIDP,
Foldindex and PONDR-FIT). (A) Distribution of predicted disor-
deredness per-residue. (B) Cumulative distribution function (CDF)
analysis of CHOP. (C) Charge-hydropathy analysis of CHOP (grey) in
comparison to natively folded proteins (closed circles) and natively
unfolded proteins (open circles).
doi:10.1371/journal.pone.0034680.g001
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well, implying that addition of L-cysteine resulted in a transition of
the CHOP protein to a more disordered state.
To analyze further the mechanism by which L-cysteine induced
unfolding, a phase diagram was constructed from the CD data
[83]. This transformation is a highly sensitive technique for
detecting intermediate conformational states [83–86]. Such a
phase diagram examines the relationship between the spectral
intensities of two wavelengths under different experimental
conditions while a protein is undergoing structural transformations
(see Methods and Materials) [83]. Given the changes observed in
both h190 and h222 with increasing amounts of L-cysteine, we
analyzed the relationship between these two parameters (Figure 3).
The relationship between two spectral parameters is expected to
be linear if changes in the protein’s environment results in an all-
or-none transition between two conformations or, in our case, a
‘‘melting’’ of the structure. In contrast, our analysis revealed the
existence of two linear dependencies, which is reflective of
sequential conformational transitions in CHOP.
In order to confirm that the L-cysteine-induced conformational
changes in CHOP differ from those involved in temperature-
induced melting of this protein, the far-UV CD spectra were taken
at increasing temperatures, ranging from 20uCt o8 0 uC. This
Figure 2. Global conformational changes in CHOP in the presence of L-cysteine measured using CD analysis. Far -UV CD spectra of
CHOP were recorded on an OLIS RMS CD spectrophotometer at 25uC. The sample contained 0.16 mg/mL CHOP in 10 mM phosphate buffer, pH 7.0,
and was titrated with varying concentrations of L-cysteine, as described in the figure legend. For each, a total of 8 scans were collected, each
corrected against buffer and L-cysteine blanks, and averaged. Inset: Graph depicting the decrease in [h]190,[ h]222, and secondary structure (alpha
helicity) content in the presence of varying concentrations of L-cysteine.
doi:10.1371/journal.pone.0034680.g002
Table 1. CD-based secondary structure measurements of
CHOP.
a
L-Cysteine
(mM) Helix (%)
Antiparallel
(%) Parallel (%) Turn (%) Coil (%)
0 69.1 3.0 2.5 12.3 10.2
0.0025 67.1 3.2 2.7 12.6 10.8
0.005 65.3 3.4 2.9 12.8 11.5
0.025 63.1 3.6 3.1 13.1 12.3
0.05 54.5 4.7 4.1 14.2 16.1
0.1 50.1 5.4 4.8 14.8 18.3
0.35 47.3 5.9 5.2 15.2 19.9
0.5 40.5 6.6 7.2 15.8 28.2
1 23.8 12.9 5.4 24.8 32.8
aMeasurements of CHOP were performed in 10 mM phosphate buffer (pH 7.0,
25uC), in the presence of increasing concentrations of L-cysteine. Calculations
were performed using CDNN [108].
doi:10.1371/journal.pone.0034680.t001
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temperature reflective of protein denaturation. Specifically,
increasing temperature resulted in concomitant changes in the
intensities at 190 and 222 nm, reflecting a loss of a-helicity, as
depicted by the characteristic sigmoidal curves describing the
temperature dependencies of these molar ellipticities (Figure 4, top
panel). Notably, the observed changes occurred over a relatively
large temperature range (,30uC–75uC). Transformation of this
data into a phase diagram (Figure 4, bottom panel) demonstrated a
linear relationship between h190 and h222, implying that, in
contrast to L-cysteine-induced conformational changes, tempera-
ture-induced denaturation of CHOP can be described as an all-or-
none transition. Thus, the loss of structure caused by the addition
of L-cysteine is likely not due to a ‘‘melting’’ of the protein as seen
in temperature-denaturation, but results in specific conformational
changes leading to its loss of secondary structure.
Effect of L-cysteine on thermal denaturation of CHOP
Further analysis of the effect of L-cysteine on conformational
change was performed by studying the thermal denaturation of
CHOP in the presence and absence of L-cysteine by differential
scanning calorimetry (DSC). The variation in heat capacity
associated with protein unfolding is primarily due to the changes
in hydration of side chains buried in the native state, which
become exposed to the solvent in the denatured state [87]. In the
absence of L-cysteine, thermal denaturation of CHOP resulted in a
sharp peak of heat absorption (Figure 5, top panel), with a melting
temperature of 57uC. Interestingly, in the presence of 80 mM L-
cysteine (i.e. a cysteine:CHOP ratio of 8:1), the CHOP heat
absorption peak widened and became asymmetrical, suggesting
that, under these conditions, thermal denaturation is a multi-step
process. Deconvolution of the normalized heat absorption peak
(Figure 5, middle panel) shows the presence of two overlapping
peaks, suggesting the presence of at least two individual
calorimetric units with melting temperatures of 52uC and 63uC,
respectively. Further increase in the L-cysteine concentration to
4 mM (Figure 5, bottom panel), led to the complete disappearance
of the cooperative heat absorption, suggesting that under these
conditions (i.e. a cysteine:CHOP ratio of 400:1), CHOP has lost
any rigid structure that it may have had in its native state [88].
NMR analysis of L-cysteine-induced structural changes in
CHOP
To investigate further the structural changes resulting from the
addition of L-cysteine to CHOP, we utilized NMR spectroscopy to
monitor the conformation of CHOP in the absence and presence
of the amino acid (Figure 6). The limited dispersion of resonances
in the proton dimension of the
1H-
15N HSQC spectrum of CHOP
is indicative of an unstructured protein. Addition of L-cysteine
resulted in chemical shift changes in resonances corresponding to
glycine backbone amide groups and asparagine and glutamine side
chain amide groups, further supporting a change in CHOP
conformation in the presence of L-cysteine.
Discussion
In our previous study, we reported that CHOP is an IDP that
contains extensive disordered regions and self-associates in
solution. The N-terminal region was found to mediate this
oligomerization and was vital for the functional roles of CHOP
Figure 3. Phase diagram showing the dependence of [h]190 vs.
[h]222 on increasing L-cysteine concentrations. Data was adapted
from Figure 2. Note the two-state linear regression, which is
representative of consecutive conformational transitions in CHOP.
doi:10.1371/journal.pone.0034680.g003
Figure 4. Thermal denaturation of CHOP measured using far-
UV CD. Top panel shows a graph depicting the changes in [h]190 and
[h]222 with at increasing temperatures. Far-UV CD spectra of CHOP were
recorded at increasing temperatures (20uC–80uC) on an OLIS RMS CD
spectrophotometer with a Pt100 thermal probe fitted right under the
cuvette. Temperatures in the cuvette were controlled using a Julabo
F30-C circulating water bath. A total of 8 scans were conducted at each
temperature and averaged, with 10 minutes of equilibration time
between each experiment. Bottom panel depicts a phase diagram
showing the dependence of [h]190 vs. [h]222 on temperature. Note that
the linear regression is representative of an all-or-none transition.
doi:10.1371/journal.pone.0034680.g004
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sucrase-isomalatase reporter activity in intestinal colon cancer cells
[57]. We expanded our structural analysis of CHOP, using a
comprehensive in silico analysis to provide further support that it is
an IDP. Since CHOP is a ‘‘hub’’ protein that has integral and
multiple roles in the UPR pathway, we looked at means by which
CHOP could be regulated. A unique functional feature of IDPs is
their binding promiscuity since their highly dynamic and flexible
structure allows a single region of disorder to adopt different
conformations using the same amino acids to varying extents in
order to bind a variety of partners [54,89].
The fact that intracellular thiols play critical roles in the
regulation of ER protein synthesis and folding, and that CHOP is
involved in responding to ER stress further supported our strategy
for screening thiol compounds. Using a combination of CD, DSC
and NMR, we were able to demonstrate that addition of free L-
cysteine is able to modify the conformation of CHOP to a more
‘‘disordered’’ state. This was not a general effect of thiols as neither
D-cysteine, homocysteine nor glutathione had any effect on the
protein secondary structure. CD analysis showed an a-helical
content of 69% in the native state which was reduced in a
concentration dependent manner until reaching 24% in the
presence of 1 mM L-cysteine. Given that CHOP is an IDP, such a
high a-helical content in its native state in the absence of L-cysteine
seems counter-intuitive. However, we have demonstrated that
CHOP exists as an oligomer in solution, and that its C-terminus is
strongly predicted to form a coiled-coil, which may account for the
a-helical signal observed by the CD analysis.
The addition of L-cysteine appears to cause a complex,
multistage transition to a more disordered state, as demonstrated
by the analysis of the CD-based phase diagrams. This is in a
contrast to the thermal melting of CHOP in the absence of L-
cysteine, which appears to be a two-state process, as further
confirmed by the DSC analyses of thermally denatured protein in
the presence and absence of L-cysteine. While the native protein
experienced a sharp transition from a native to an ‘‘unfolded’’
state, the addition of L-cysteine appeared to cause the formation of
two independent calorimetric units. Furthermore, excess L-cysteine
resulted in the complete disintegration of rigid, cooperatively
melting structure of the protein. While this marks a serendipitous
discovery of cysteine modulating the conformation of CHOP, its
ability to do so is not entirely novel. The thiol group of cysteine,
usually important in the antioxidation of ROS and free radicals
[90,91], was found to act as a radical mediator, inducing
conformational changes in the secondary structure of bovine
serum albumin in the presence of UV-B irradiation which was
suggested to cause a progressive transformation from a-helix to an
intermolecular b-sheet structure [92].
The specific ability of L-cysteine, and not glutathione, to cause
such effects is not unusual. While the glutathione/glutathione
disulfide (GSH/GSSG) redox pair does constitute the most
prominent cellular redox pair [93], it is the cysteine/cystine
(Cys/CySS) couple which predominates in the plasma [94].
Furthermore, the steady-state redox potential of the two pairs is
regulated independently of each other [95–97], with that of
plasma Cys/CySS being oxidized during oxidative stress [98,99].
Indeed, selective oxidation of Cys/CySS was observed, with no
change in the oxidation state of GSH/GSSG, in the acute phase of
endotoxin-induced lung injury in mice [100].
There are several accounts pointing to the physiological
importance of cysteine. In the aforementioned Iyer et al. study
reporting on endotoxin-induced lung injury in mice, enhanced
oxidation of Cys, altered transport of Cys and CySS and decreased
food intake each contributed to the oxidation of the plasma Cys/
CySS redox state in endotoxemia [100]. In yeast, exogenous
addition of homocysteine and cysteine was found to inhibit
growth, not due to oxidative stress, but putatively due to ER stress
resulting in the upregulation of transcription of metabolic genes as
a strategy to reduce intracellular thiol concentrations [64]. We
have already stated that levels of CHOP are modulated under
homocysteine stress [61] while its translocation occurs under redox
Figure 5. Thermal denaturation profile of CHOP measured
using DSC. Top panel: Normalized DSC scan of CHOP in 5 mM
phosphate buffer (pH 7.0) in the absence (solid triangle) or presence
(open circle) of 80 mM L-cysteine. Middle panel: Two-state fitting
(dashed line) of normalized DSC scan of CHOP in presence of 80 mM L-
cysteine. Bottom panel: Normalized DSC scan of CHOP in presence of
4m ML-cysteine. The heating rate was 45uC per hour. Approximately
10 mM CHOP was used for each run.
doi:10.1371/journal.pone.0034680.g005
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aberrant-ER marker, and intracellular thiols such as cysteine,
homocysteine and glutathione play critical roles in the regulation
of ER protein synthesis and folding [64]. Furthermore, translo-
cation through membranes is thought to be optimal when a target
globular protein is converted into a ‘‘molten globule’’-like
conformation and possesses the necessary combination of
structural features typical for folded and unfolded proteins [63].
Plasma concentrations of cysteine have been reported in the range
of 214–260 mM [101,102]. There is limited information about the
exact amount of cysteine present inside the ER lumen but
intracellular concentrations of thiols has been shown to be in the
millimolar range [103] with relatively higher concentrations of
oxidized glutathione in the ER lumen to facilitate native disulfide
bond formation [104]; thus, it is not unlikely for the ER lumen to
have a higher localized concentration of cysteine. Of note, studies
examining the cysteine-mediated growth defect in yeast by Kumar
et al. were performed at similar and up to five times greater
cysteine concentrations than in our study [64]. Thus, one may
envision a scenario in which high cysteine levels as a result of ER/
oxidative stress may result in CHOP adopting a more disordered
conformation and dissociate from its oligomeric state into one that
is more suitable for the subsequent translocation through the
membrane. This may facilitate membrane translocation to where
it is most needed, resulting in apoptosis, or other CHOP-induced
processes. Further analysis of this hypothesis is required.
In conclusion, we have identified the specific ability of L-
cysteine, and not homocysteine or glutathione, to cause global
conformational change in CHOP, resulting in an increase in its
disorder. Thus, this represents a means by which IDPs, such as
CHOP, can be regulated to switch between different structural
states of varying disorder, likely serving different functional roles.
Materials and Methods
In silico analysis of CHOP
Disorder predictions for CHOP were performed using the
IVLXT, VSL2, VL3, IUPred, TopIDP, Foldindex and PONDR-
FIT programs [31,41–46].
Figure 6. Two-dimensional
1H-
15N-HSQC spectra of CHOP in the absence (background) and presence of 2 mM (inset A) and 8 mM
(inset B) L-cysteine at 46C. Circles identify backbone
1H-
15N resonances affected by L-cysteine while arrows identify a region comprising side chain
amide resonances affected L-cysteine.
doi:10.1371/journal.pone.0034680.g006
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Cloning, expression and purification of CHOP were performed
as described previously [57].
Circular dichroism (CD)
CD analyses were performed at 25uC, using an OLIS RSM CD
spectrophotometer. Far-UV and near-UV CD analyses were
performed using CHOP protein concentrations of 10 mM and
25 mM, and path-lengths of 0.1 cm and 1 cm, respectively. The
spectrophotometer was purged with pure N2 during the course of
the experiment. Each CD plot was calculated from an average of
eight accumulated scans, which were baseline-corrected using the
relevant buffer. The molar ellipticity, [h], was calculated from the
observed ellipticity h, using the equation [h]=h6100/ncl, where n
is the number of amino acids in the protein, c is the molar protein
concentration and l is the path length of the cell in centimetres.
Deconvolution of the data and secondary structure analysis was
performed using CDNN software [82].
Phase diagram analysis of conformational changes
The ‘‘phase diagram’’ method, a highly sensitive technique for
detecting intermediate conformational states from fluorescence or
spectroscopic data [83,83–86], was utilized to analyze changes in
CHOP conformation. Values of [h]190 and [h]222 in the presence
of varying concentrations of L-cysteine were plotted against each
other. The essence of this method is to graph Il1 versus Il2, where
Il1 and Il2 are the spectral intensity values measured at
wavelengths l1 and l2 under different experimental conditions
for a protein undergoing structural transformations. As spectral
intensity is an extensive parameter, it will describe any two-
component system by the relationship I(l)=a1 I1(l)+a2 I2(l),
where I1(l) and I2(l) are the intensities of the first and second
components, and a1 and a2 are their relative concentrations
(a1+a2=1). It can then be derived [80] that I(l1)=a+bI(l2),
where a~I1(l1){
I2(l1){I1(l1)
I2(l2){I1(l2)
I1(l2) and b~
I2(l1){I1(l1)
I2(l2){I1(l2)
:
In application to protein unfolding, this predicts that
I(l1)~f(I(l2)) will be linear if changes in the protein’s
environment lead to an all-or-none transition between two
different conformations. Alternatively, non-linearity of the func-
tion reflects sequential character in structural transformations. In
this case, each linear portion of the I(l1)~f(I(l2)) dependence
will describe an individual all-or-none transition [105].
Differential scanning calorimetry
Thermal denaturation studies were performed using a VP-DSC
calorimeter (Microcal Inc., Northampton, MA) which heated the
protein from 20uCt o8 5 uC at a rate of 45uC/h. Prior to analysis,
samples were dialyzed overnight in 4 L of buffer containing
10 mM Na2HPO4, 1.8 mM KH2PO4 (pH 7.3), 140 mM NaCl,
and 2.7 mM KCl. The dialysis buffer was filtered using a 0.22-mm
filter (Millipore, Billerica, MA) and used to obtain a baseline from
several buffer-buffer scans. Protein-buffer scans were performed at
a final protein concentration of 0.2 mg/mL. Protein samples were
assessed for aggregation by monitoring A340 at various time
intervals. Data analyses were performed using Microcal Origin 5.0
(Microcal Inc., Northampton, MA).
NMR Spectroscopy
Two-dimensional
1H-
15N HSQC NMR spectra of 0.4 mM
uniformly
15N-labeled CHOP were recorded using a Varian
INOVA 600 MHz spectrometer equipped with a pulse field
gradient triple resonance cryoprobe at 4uC. The experiments were
carried out in PBS (pH 6.8) containing 90% H2O/10% D2O,
using the enhanced sensitivity pulsed-field gradient approach.
Carrier frequencies of 4.77 ppm (
1H), and 118 ppm (
15N) were
used and
1H chemical shifts were calibrated relative to the
trimethylsilyl resonance (0.0 ppm) of 2,2-dimethyl-2-silapentane-
5-sulfonate (DSS). Spectra were processed and analyzed using
NMRPipe [106] and NMRview [107], respectively.
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